Real-time enrollment status for this graves' disease clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:35 PM UTC
| NCT Number | NCT07682896 |
| Recruiting Status | Recruiting |
| Condition | Graves' Disease |
| Phase | PHASE2 |
| Target Enrollment | 232 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Yarrow Bioscience, Inc. |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07682896 is currently recruiting participants. This phase2 study for graves' disease is actively seeking new participants at 27 locations across the United States. The study is sponsored by Yarrow Bioscience, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07682896 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07682896 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.